Quest Diagnostics Overview
Quest Diagnostics Target Price
Analysts' average 12-month price target for Quest Diagnostics is $250.
Get informed when a big investor buys or sells
+ FollowShare Price
$247.45
Average Target Price
$246.14
0.5% downside
0.5% downside7 analysts in the last 4 months
High: $260 | Low: $232
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-09-08 | UBS | $245 | 1% downside |  |
| 2026-07-29 | Argus Research | $260 |  5.1% upside | |
| 2026-07-24 | UBSKevin Caliendo | $232 | 6.2% downside | |
| 2026-07-24 | Robert W. Baird | $255 | 3.1% upside | |
| 2026-07-23 | Barclays | $250 | 1% upside | |
| 2026-07-23 | Jefferies | $245 | 1% downside | |
| 2026-07-13 | Robert W. Baird | $236 | 4.6% downside | |
| 2026-04-21 | Evercore ISI | $225 | 9.1% downside | |
| 2026-04-21 | Jefferies | $225 | 9.1% downside | |
| 2026-04-08 | Evercore ISI | $210 | 15.1% downside | |
| 2026-02-12 | Mizuho Securities | $235 | 5% downside | |
| 2026-02-11 | UBS | $210 | 15.1% downside | |
| 2026-02-11 | Truist Financial | $220 | 11.1% downside | |
| 2026-02-11 | Evercore ISIElizabeth Anderson | $220 | 11.1% downside | |
| 2026-02-11 | Robert W. Baird | $219 | 11.5% downside | |
| 2026-02-10 | JefferiesTycho Peterson | $220 | 11.1% downside | |
| 2026-01-30 | Barclays | $210 | 15.1% downside | |
| 2025-10-27 | Piper Sandler | $200 | 19.2% downside | |
| 2025-10-22 | Truist Financial | $205 | 17.2% downside | |
| 2025-10-22 | Morgan StanleyErin Wright | $207 | 16.3% downside | |
| 2025-10-22 | Barclays | $195 | 21.2% downside | |
| 2025-10-21 | Jefferies | $215 | 13.1% downside | |
| 2025-10-21 | Leerink Partners | $210 | 15.1% downside | |
| 2025-10-17 | UBSKevin Caliendo | $190 | 23.2% downside | |
| 2025-10-17 | Mizuho Securities | $210 | 15.1% downside | |
| 2025-10-14 | Truist Financial | $195 | 21.2% downside | |
| 2025-10-08 | Evercore ISI | $190 | 23.2% downside | |
| 2025-10-02 | Barclays | $190 | 23.2% downside | |
| 2025-08-25 | Robert W. Baird | $194 | 21.6% downside | |
| 2025-07-23 | Evercore ISIElizabeth Anderson | $185 | 25.2% downside | |
| 2025-04-02 | Redburn PartnersJamie Clark | $195 | 21.2% downside | |
| 2025-02-03 | Piper SandlerDavid Westenberg | $180 | 27.3% downside | |
| 2025-01-31 | Truist FinancialDavid MacDonald | $182 | 26.4% downside | |
| 2025-01-31 | Robert W. BairdEric Coldwell | $189 | 23.6% downside | |
| 2024-10-23 | CitigroupPatrick Donnelly | $185 | 25.2% downside | |
| 2024-10-23 | Leerink PartnersMichael Cherny | $165 | 33.3% downside | |
| 2024-10-23 | BarclaysStephanie Davis | $168 | 32.1% downside | |
| 2024-10-23 | Robert W. BairdEric Coldwell | $182 | 26.4% downside | |
| 2024-10-22 | CFRAPaige Meyer | $178 | 28.1% downside | |
| 2024-10-07 | Truist FinancialDavid MacDonald | $165 | 33.3% downside | |
| 2024-07-29 | Mizuho SecuritiesAnn Hynes | $160 | 35.3% downside | |
| 2024-07-24 | Robert W. BairdEric Coldwell | $154 | 37.8% downside | |
| 2024-07-15 | Truist FinancialDavid MacDonald | $158 | 36.1% downside | |
| 2024-04-25 | BarclaysStephanie Davis | $144 | 41.8% downside | |
| 2024-02-07 | JefferiesBrian Tanquilut | $155 | 37.4% downside | |
| 2023-02-03 | Wells Fargo | $140 | 43.4% downside | |
| 2023-01-06 | Morgan Stanley | $158 | 36.1% downside | |
| 2022-11-17 | Citigroup | $125 | 49.5% downside | |
| 2022-05-03 | Morgan Stanley | $142 | 42.6% downside | |
| 2022-04-25 | Wells Fargo | $150 | 39.4% downside | |